Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03613363 · ClinicalTrials.gov registry record · NA

Engineering Evaluation of the Helix Ventilator

A NA study of Pediatric ALL and Pulmonary Disease, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03613363 is a NA study of Pediatric ALL and Pulmonary Disease that has completed, run by Philips Respironics. The registered enrollment target is 20 participants, below the 1,647-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03613363, a NA study of Pediatric ALL and Pulmonary Disease, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will be used to evaluate and observe the overall performance and controls of the Helix ventilator. Pressure and flow data between participants' current devices and the Helix ventilator will be assessed in either invasive or non-invasive ventilation. To evaluate ventilator performance, pressure and waveform data will be assessed as well. Also, patient and caregiver feedback will be captured. The target population is infants to adults weighing more than 5kg. Participants will be recruited by Boston Children's Health Physician's Group. Up to thirty participants will be enrolled in the study.

Interventions

  • DEVICE Helix Ventilator

Study Locations (1)

New York

  • New York Medical College - Hawthorne

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-06-06
Est. Completion 2021-09-07
Phase NA

Sponsor

Philips Respironics

35 total trials

What the Registry Record Tells You About NCT03613363

The ClinicalTrials.gov registry entry for NCT03613363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,647-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower). The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Helix Ventilator is the first listed.

NCT03613363 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03613363 about?

NCT03613363 is a clinical study titled "Engineering Evaluation of the Helix Ventilator". This study will be used to evaluate and observe the overall performance and controls of the Helix ventilator. Pressure and flow data between participants' current devices and the Helix ventilator will be assessed in either invasive or non-invasive ventilation. To evaluate ventilator performance, pre...

What is the current status of trial NCT03613363?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-06-06. Estimated completion is 2021-09-07.

What conditions does trial NCT03613363 study?

This clinical trial studies the following conditions: Pediatric ALL, Pulmonary Disease, Respiratory Disease.

What interventions are being tested in trial NCT03613363?

The interventions under investigation include: Helix Ventilator (DEVICE).

Who is sponsoring clinical trial NCT03613363?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03613363 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric ALL

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.